A case of extramedullary plasmacytoma (EMP) of the jejunum, an uncommonneoplasia, is reported. A 56-year-old Japanese womanwhoexperienced intermittent upper abdominal pain and weight loss had a large movablemassin the upper abdomen.The mass washypervascular in an (Internal Medicine 35: 422-426, 1996) 
Introduction
Plasmacytomais a neoplastic proliferation of plasma cells that commonly occurs in bone marrow but which may develop in tissues throughout the body. Only 4% of plasma cell tumors are reported to originate outside the bone marrow (1) . Primary extramedullary plasmacytomas (EMP), defined as a plasma cell tumor having less than 5% bone marrow plasma cells (2) , frequently occur in the upper respiratory system or oral cavity. Only 3% to 13% of the EMPs develop in the gastrointestinal tract, the stomach being the most frequent site (1, (3) (4) (5) (6) , and the jejunum rarely. In Japan only 5 cases ofjejunal EMPhave been reported to date (7-ll, Table 1 ). Here we describe a case of EMPin the jejunum of a 56-year-old Japanese womanand the clinical features of this rare condition.
Case Report
A 56-year-old Japanese womanwas admitted to Miyazaki Medical College Hospital on January 19, 1994 because of upper abdominal pain and weight loss. She had felt a movable hard mass in the upper abdomensince August 1993 and had suffered intermittent upper abdominal pain during recent months. The pain often worsened and was accompaniedby borborygmus, especially after eating, and she had vomited once 2 weeks prior to admission and voided stools every day before admission. She had lost 10 kg in the year prior to admission. No hematological disorder or intestinal parasitic infestation was noted in her past history. Twoovariectomy procedures had been performed for ovarian cysts, once in 1968 and in September 1993. On physical examination, the palpebral conjunctiva was slightly anemic, and there was a movable hard mass (6x10 cm) with an irregular surface that was palpable in the left upper abdomen. Laboratory findings ( eosinophils, 1%; and basophils, 2%. Serum total protein was 6.3 g/dl with 1.5 g/dl p-globulin and 1.2 g/dl y-globulin. The concentrations of the serum transaminases and calcium were within the normal ranges. The serum immunoglobulin levels were IgG 1,220mg/dl; IgA 1 ,330mg/dl; IgM 137 mg/dl andIgE 72.5 IU/ml. IgA was markedly increased, whereas the other immunoglobulinconcentrations werewithin the normal range. Serum immunoelectrophoresis showed the presence of monoclonal IgA-A,. No Bence Jones protein was detected in the urine. Repeatedexaminations of bonemarrowaspirates showed no abnormal proliferation of plasma cells. Extensive X-ray bone survey showedno abnormalities. Abdominalcomputed tomography (CT) showed the presence of a very large mass of soft tissue density on an intestinal lumen of the small intestine ( Fig. 1) . A double contrast study of the small intestine showed a protruding lesion (10x12 cm) with an ulcer in the portion of the jejunum 80 cm distal from Treitz's ligament (Fig. 2) . Gallium-67 citrate scintigraphy showed an abnormal accumulation of the radioisotope in the mass (Fig. 3 ). (present case) Palpable mass prednisolone)
Refers to references given in this paper, a) primary therapy, being surgery (S), chemotherapy (C). b) Relapse, being local recurrence (LR). c) Total survival (years) from time of diagnosis, still alive (+) or having died (-). -: no description. both the greater omentumand the transverse colon. Swelling of the small mesenteric lymphnodes was noted. The resected tumormeasured 13 x 12 x 9 cm andweighed 860 g ( Fig. 5A and  B) . A histological examination showed that it was composed of a proliferation of atypical plasma cells with eccentric nuclei and a cytoplasm positive for pyronine staining (Fig. 6 ). In addition, the infiltrating plasma cells were igA-X positive. Although the swollen mesenteric lymph nodes contained scattered plasma cells, there was no apparent tumor cell proliferation. The mass therefore was diagnosed as a plasmacytoma of the jejunum. The serum IgA rapidly returned to an almost normal value (325 mg/dl), and the serum M-component disappeared within 2 months after resection of the tumor. Noabnormalaccumulation resulted from gallium-67 citrate scintigraphy done after surgery. The patient received two cycles of chemotherapy with melphalan (6.5 mg/m2) and prednisolone (60 mg/m2) for 4 days. The last treatment was given in April 1994; no recurrence or metastasis of the plasmacytoma has since been detected for nearly two years. 
Discussion
We have described a case of EMPof the jejunum, an uncommonneoplastic disorder. Plasmacytoma is reported to be commonin the 40-to 70-year-old group, and the ratio of men to womenis reported Clinical manifestations of EMPin the GI tract depend on the organs affected. Abdominal pain, obstruction, intussusception, bleeding, and ileocolic fistula have all been reported as GI symptoms of EMP (5, 13) . Double contrast roentgenographic findings for intestinal EMPare similar to those of carcinoma, lymphoma, other solitary or multiple polypoid lesions, and inflammatory stricture of the intestine (13). Neither an angiographic nor a gallium-scintigraphic feature, however, has previously been described for intestinal EMP. This is because in the previous reports, patients with intestinal EMPhad been admitted to hospitals due to acute abdominal pain, and surgery was done without making a detailed examination for EMP.The jejunal EMPof the present case was a hypervascular tumor fed by both the superior mesenteric and celiac arteries. In addition, it was positive for gallium-67 scintigraphy. To our knowledge, this is the first report that describes angiographic and galliumscintigraphic findings of an intestinal EMP. Unlike patients with multiple myelomaor solitary plasmacytomaof the bone, patients with EMP rarely have been reported to have M-component in their sera or Bence Jones protein in their urine ( 14). An M-component of the igA-X type, however, was present in the serum of the present patient, but there was no Bence Jones protein in her urine. Salmonand Smith reported that a tumor must weigh more than 10 g in order to be able to detect whether the M-component is present in the serum of a patient (1 5) . Because the EMPsreported previously were all smaller than our patient's EMP(860 g), the large size of her tumor may explain the presence of the M-component. In any case, the fact that the serum M-componentdisappeared following resection of the tumor suggests that this component serves as a good marker for evaluating the effect of chemotherapy and for the early detection of the recurrence of metastasis of this type of the tumor.
Wehave described a case of EMPin the jejunum that produced an M-component ofIgA-A,. To our knowledge, this is the first report detailing both the angiographic and gallium-67 scintigraphic features of an intestinal EMP.
